The Michael J. Fox Foundation for Parkinson's Research is dedicated to finding a cure for Parkinson's disease through an aggressively funded research agenda and to ensuring the development of improved therapies for those living with Parkinson's today. Established by actor Michael J. Fox in 2000, the Foundation has since become the largest private funder of Parkinson's disease research in the world, investing nearly $179 million in research to date. In 2010 the Fox foundation launched the first large-scale clinical study on evolution biomarkers of the disease with a cost of 40 million dollars in 5 years.
The Foundation targets underfunded, high-risk, "translational" research—the work of translating basic scientific discoveries into practical treatments with potential to benefit the estimated five million people living with Parkinson's today. The Foundation's research team, drawn from the worlds of both science and business, proactively manages the largest PD research portfolio in the world, prioritizing the most promising ideas and key studies to ensure that they continue on a strategic course forward.